Biomarin Pharmaceutical Inc

VANGUARD GROUP INC BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

18,127,847

Value ($000)

1,077,338

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	1,077,338	0.0%	18,127,847	12/31/2025
2025 Q3	11/7/2025	1,006,433	0.0%	18,582,585	9/30/2025
2025 Q2	8/11/2025	1,044,641	0.0%	19,003,832	6/30/2025
2025 Q1	5/9/2025	1,343,337	0.0%	19,003,212	3/31/2025
2024 Q4	2/11/2025	1,273,334	0.0%	19,372,185	12/31/2024
2024 Q3	11/13/2024	1,355,097	0.0%	19,278,654	9/30/2024
2024 Q2	8/13/2024	1,563,779	0.0%	18,994,038	6/30/2024
2024 Q1	5/10/2024	1,582,348	0.0%	18,117,108	3/31/2024
2023 Q4	3/11/2024	1,740,387	0.0%	18,050,062	12/31/2023
2023 Q3	12/18/2023	1,566,203	0.0%	17,701,210	9/30/2023
2023 Q2	8/14/2023	1,537,851	0.0%	17,741,706	6/30/2023
2023 Q1	7/14/2023	1,704,933	0.0%	17,533,246	3/31/2023
2022 Q4	2/10/2023	1,797,112	0.0%	17,365,080	12/31/2022
2022 Q3	11/14/2022	1,450,270	0.0%	17,108,289	9/30/2022
2022 Q2	8/12/2022	1,395,932	0.0%	16,844,836	6/30/2022
2022 Q1	5/13/2022	1,272,322	0.0%	16,502,243	3/31/2022
2021 Q4	2/14/2022	1,444,614	0.0%	16,351,031	12/31/2021
2021 Q3	11/12/2021	1,260,334	0.0%	16,306,557	9/30/2021
2021 Q2	8/13/2021	1,353,613	0.0%	16,222,594	6/30/2021
2021 Q1	5/14/2021	1,234,917	0.0%	16,354,349	3/31/2021
2020 Q4	2/12/2021	1,435,458	0.0%	16,369,689	12/31/2020
2020 Q3	11/16/2020	1,242,801	0.0%	16,335,436	9/30/2020
2020 Q2	8/14/2020	2,086,734	0.1%	16,918,551	6/30/2020
2020 Q1	5/15/2020	1,432,786	0.1%	16,956,050	3/31/2020
2019 Q4	2/14/2020	1,398,185	0.0%	16,536,780	12/31/2019
2014 Q2	8/11/2014	511,782	0.0%	8,226,701	6/30/2014
2014 Q1	5/13/2014	547,803	0.0%	8,031,118	3/31/2014
2013 Q4	2/12/2014	535,083	0.0%	7,614,627	12/31/2013